Receptor-ligand interaction between CD44 and osteopontin (Eta-1) (vol 271, pg 509, 1996)

被引：0
|
作者：
Weber, GF [1 ]
Ashkar, S
Glimcher, MJ
Cantor, H
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA
来源：
SCIENCE | 1998年 / 282卷 / 5387期
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [41] N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis (Vol 211, pg 259, 2022)
    Chen, Qiang
    Guo, Chunjing
    Zhou, Xiudi
    Su, Yanguo
    Guo, Huimin
    Cao, Min
    Li, Jing
    Zhang, Yue
    Zhao, Wenyi
    Gao, Xin
    Mi, Shuqi
    Chen, Daquan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 270
  • [42] Regulation of phospholipase C-beta 1 by G(q) and m1 muscarinic cholinergic receptor. Steady-state balance of receptor-mediated activation and GTPase-activating protein-promoted deactivation (vol 271, pg 7999, 1996)
    Biddlecome, GH
    Berstein, G
    Ross, EM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (52) : 33705 - 33705
  • [43] Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.(Vol 12, pg 477, 2017)
    Cho, H.
    Matsumoto, S.
    Fujita, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (05) : 900 - 900
  • [44] Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling (vol 12, pg 929, 2022)
    Sun, Xun
    Li, Kexin
    Hase, Misato
    Zha, Rongrong
    Feng, Yan
    Li, Bai-Yan
    Yokota, Hiroki
    THERANOSTICS, 2023, 13 (01): : 16 - 19
  • [45] THE IDENTIFICATION OF A NEW ALTERNATIVE EXON WITH HIGHLY RESTRICTED TISSUE EXPRESSION IN TRANSCRIPTS ENCODING THE MOUSE PGP-1 (CD44) HOMING RECEPTOR - COMPARISON OF ALL 10 VARIABLE EXONS BETWEEN MOUSE, HUMAN, AND RAT
    SCREATON, GR
    BELL, MV
    BELL, JI
    JACKSON, DG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (17) : 12235 - 12238
  • [46] Is 1,25-Dihydroxyvitamin D3 Receptor Expression a Potential Achilles' Heel of CD44+ Oral Squamous Cell Carcinoma Cells? (vol 8, pg 189, 2013)
    Grimm, Martin
    Shokri, Beshr
    Alexander, Dorothea
    Munz, Adelheid
    Hoffmann, Juergen
    Reinert, Siegmar
    TARGETED ONCOLOGY, 2017, 12 (05) : 703 - 703
  • [47] Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation (vol 271, pg 30222, 1996)
    Harada, S
    Smith, RM
    Smith, JA
    White, MF
    Jarett, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) : 3124 - 3124
  • [48] ADHESION OF COMMITTED HUMAN HEMATOPOIETIC PROGENITORS TO SYNTHETIC PEPTIDES FROM THE C-TERMINAL HEPARIN-BINDING DOMAIN OF FIBRONECTIN - COOPERATION BETWEEN THE INTEGRIN ALPHA-4-BETA-1 AND THE CD44 ADHESION RECEPTOR
    VERFAILLIE, CM
    BENIS, A
    IIDA, J
    MCGLAVE, PB
    MCCARTHY, JB
    BLOOD, 1994, 84 (06) : 1802 - 1811
  • [49] Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): Evidence for a secondary cellular factor in A-particle formation (vol 71, pg 9308, 1997)
    Powell, RM
    Ward, T
    Evans, DJ
    Almond, JW
    JOURNAL OF VIROLOGY, 1998, 72 (01) : 890 - 890
  • [50] Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers (vol 66, pg 312, 2004)
    Ayoub, MA
    Levoye, A
    Delagrange, P
    Jockers, R
    MOLECULAR PHARMACOLOGY, 2004, 66 (03) : 771 - 771
12345